New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels

____________________________________

¹Leiter, L.A., et al., Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes, 2013. 37(2): p. 82-9.

²https://www.diabetes.ca/about-diabetes.

³Leiter, L.A., et al., Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes, 2013. 37(2): p. 82-9.

⁴https://link.springer.com/article/10.1007/s13300-018-0375-7.

⁵Khunti, K., et al., Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab, 2016. 18(4): p. 401-9.

⁶Paul, S.K., et al., Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovascular Diabetology, 2015. 14(1): p. 100.

⁷Khunti, K., Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review. The British Journal of Diabetes, 2015. 15(2): p. 65-69.

⁸Khunti, K., et al., Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care, 2013. 36(11): p. 3411-7. doi: 10.2337/dc13-0331. Epub 2013 Jul 22.

⁹Polonsky, W.H. and R.A. Jackson, What's So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes. Clinical Diabetes, 2004. 22(3): p. 147-150.

¹⁰DeFronzo, R.A., R. Eldor, and M. Abdul-Ghani, Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care, 2013. 36 Suppl 2: p. S127-38.

¹¹Pratley, R.E., The early treatment of type 2 diabetes. Am J Med, 2013. 126(9 Suppl 1): p. S2-9.

¹²Barag, S.H., Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence. J Am Osteopath Assoc, 2011. 111(7 Suppl 5): p. S13-9.

¹³Ross, S.A., Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med, 2013. 126(9 Suppl 1): p. 012.

¹⁴Palumbo, P.J., The case for insulin treatment early in type 2 diabetes. Cleve Clin J Med, 2004. 71(5): p. 385-6.

¹⁵Ritzel, R., Roussel, R., Bolli, G. B., Vinet, L., Brulle-Wohlhueter, C., Glezer, S., & Yki-Järvinen, H., Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes, Obesity and Metabolism, 2015. 17(9), 859-867.